Detection of Macrophage Migration Inhibitory Factor (MIF) in Human Cholesteatomas and Functional Implications of Correlations to Recurrence Status and to Expression of Matrix Metalloproteinases‐3/9, Retinoic Acid Receptor‐β, and Anti‐apoptotic Galectin‐3
- 1 September 2001
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 111 (9) , 1656-1662
- https://doi.org/10.1097/00005537-200109000-00031
Abstract
Objectives To investigate whether the expression of the macrophage migration inhibitory factor (MIF) 1) is detectable, 2) changes in relation to recurrence and infection status, and 3) relates to the levels of expression of growth regulators/differentiation markers, including galectin‐1, ‐3, and ‐8, retinoid acid receptors (RAR)]‐α, ‐β, and ‐γ, binding sites for sarcolectin, and invasion markers (cathepsins ‐B and ‐D, and matrix metalloproteinases [MMP]‐2, ‐3, and ‐9) in human cholesteatomas.Study Design An analysis of 56 cholesteatomas resected by the same surgeon using canal wall up and canal wall down surgical procedures.Methods The immunohistochemical levels of expression of MIF and the proteases were quantitatively determined (using computer‐assisted microscopy) on routine histologic slides by specific antibodies, and statistically correlated to parameters of the other markers determined previously in conjunction with data on apoptosis/proliferation.Results MIF expression was detected. It was significantly higher in the epithelium (P = .002) and vessels (P = .04) of the connective tissues (but not in the connective tissue itself) of recurrent as opposed to non‐recurrent cholesteatomas. The MIF expression is significantly correlated (P = .006) to the RARβ expression in non‐infected cholesteatomas, and to MMP‐3 (P <.01) and anti‐apoptotic galectin‐3 (P = .01) in infected cholesteatomas. The level of MIF expression was also correlated significantly to MMP‐9 (P = 0.003), RARβ (P <.001), and galectin‐8 (P = .003) expression in the cholesteatomas regardless of their infection status.Conclusions MIF expression in human cholesteatomas is related to the levels of biologic aggressiveness reflected in their recurrence status and MMP expression, and to the differentiation status reflected in their galactin and RARβ expressions. Together with galectin‐3, it could cooperate to form an anti‐apoptotic feedback loop.Keywords
This publication has 38 references indexed in Scilit:
- Evidence for a role of macrophage migration inhibitory factor in psoriatic skin diseaseBritish Journal of Dermatology, 1999
- A Proinflammatory Cytokine Inhibits P53 Tumor Suppressor ActivityThe Journal of Experimental Medicine, 1999
- Ultraviolet B Radiation Upregulates the Production of Macrophage Migration Inhibitory Factor (MIF) in Human Epidermal KeratinocytesJournal of Investigative Dermatology, 1999
- Retinoic Acid Receptor-γ in Human Epidermis Preferentially Traps All-Trans Retinoic Acid as its Ligand Rather Than 9-cis Retinoic AcidJournal of Investigative Dermatology, 1998
- Macrophage Migration Inhibitory Factor Is an Essential Immunoregulatory Cytokine in Atopic DermatitisBiochemical and Biophysical Research Communications, 1997
- Incomplete Differentiation of Fetal Keratinocytes in the Skin Equivalent Leads to the Default Pathway of ApoptosisExperimental Cell Research, 1997
- Identification of macrophage migration inhibitory factor (MIF) in human skin and its immunohistochemical localizationFEBS Letters, 1996
- Expressions of c‐jun and p53 proteins in human middle ear cholesteatoma: Relationship to keratinocyte proliferation, differentiation, and programmed cell deathThe Laryngoscope, 1995
- Characterization of the Macrophage Migration Inhibitory Factor-Binding Site of Sarcolectin and Its Relationship to Human Serum AlbuminBiochemical and Biophysical Research Communications, 1994
- p53, guardian of the genomeNature, 1992